Girard Sharp
Dena Sharp is a trial lawyer who focuses on finding common-sense solutions in even the most complex litigation. She recently served as co-lead counsel in the In re Juul Labs Inc. multidistrict litigation, which resulted in recoveries of nearly $2 billion for individual consumers, school districts, municipalities, and Native American tribes. Dena currently serves as co-lead counsel in In re Xyrem Antitrust as well as in leadership positions in various life sciences and statutory damage matters. She also serves as a member of the End-Payer Steering Committee in the massive In re Generic Pharmaceuticals Pricing Antitrust Litigation
Dena tries cutting-edge cases. In a first-of-its-kind jury trial in 2021, Dena and team represented clients whose eggs and embryos were in a freezer tank at a fertility clinic that failed. After a three-week trial, the jury returned a $15 million verdict for the plaintiffs.
Outside the courtroom, Dena chairs the board of directors of the Impact Fund, a public interest nonprofit. She is an elected member of the American Law Institute, sits on the board of advisors of the Center for Litigation and the Courts at the UC College of the Law, San Francisco, and serves on the executive committee of the local chapter of the Federal Bar Association.
Dena has been selected as a “Titan of the Plaintiffs’ Bar” by Law360. She recently received the prestigious “California Lawyer Attorney of the Year” (CLAY) Award, and has three times been named to the National Law Journal’s “Elite Women of the Plaintiffs’ Bar,” among other accolades.
Dena is a graduate, cum laude, of the University of California College of the Law, San Francisco, and earned her undergraduate degree from Brown University, where she graduated magna cum laude. A first-generation American, Dena is fluent in Spanish and German.
